Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Aoxing Pharmaceutical Company, Inc. (AOXG) had Return on Tangible Equity of 0.88% for the most recently reported fiscal quarter, ending 2017-03-31.
Income Statement Financials | |
$5.70M |
|
$0.13M |
|
$1.28M |
|
$4.42M |
|
$4.82M |
|
$0.88M |
|
$-0.58M |
|
$0.30M |
|
$0.30M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
$0.14M |
|
$0.88M |
|
$1.12M |
|
76.21M |
|
76.21M |
|
$0.00 |
|
$0.00 |
|
Balance Sheet Financials | |
$34.80M |
|
$24.04M |
|
$27.66M |
|
$62.47M |
|
$43.97M |
|
$0.10M |
|
$0.41M |
|
$44.38M |
|
$18.09M |
|
$16.29M |
|
$18.09M |
|
76.21M |
|
Cash Flow Statement Financials | |
$-2.79M |
|
$-0.01M |
|
$3.18M |
|
$6.91M |
|
$7.08M |
|
$0.17M |
|
$0.02M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.79 |
|
-- |
|
-- |
|
0.01 |
|
1.53 |
|
77.53% |
|
15.41% |
|
15.41% |
|
-- |
|
5.21% |
|
2.32% |
|
$-2.80M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.53 |
|
0.39 |
|
228.95 |
|
0.79% |
|
Return on Tangible Equity |
0.88% |
0.23% |
|
0.79% |
|
$0.24 |
|
$-0.04 |
|
$-0.04 |